Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCNQ5 antisense RNA 1 (KCNQ5-AS1) is a long non-coding RNA located in the human genome near the KCNQ5 gene, for which it is named as an antisense transcript. Unlike protein-coding genes, KCNQ5-AS1 does not encode a protein; instead, its transcripts may play roles in regulating gene expression through mechanisms typical for lncRNAs, such as chromatin modulation, transcriptional interference, or RNA stability regulation. There is limited functional characterization in literature, with associations to tissue-specific expression or gene regulation inferred from genomic datasets. There is currently no evidence that KCNQ5-AS1 is a druggable therapeutic target, nor are there direct links between KCNQ5-AS1 and major diseases, distinguishing it from the protein-coding KCNQ5 potassium channel gene. Do not confuse KCNQ5-AS1 (non-coding RNA) with KCNQ5 (potassium channel protein), which is a bona fide therapeutic target in neurology and ophthalmology. KCNQ5-AS1 remains primarily of functional and genomic research interest, not direct clinical relevance at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KCNQ5 antisense RNA 1 (non-protein coding) (KCNQ5-AS1).